PMID: 15248834Jul 14, 2004Paper

Adiponectin may play a part in the pathogenesis of diabetic retinopathy

European Journal of Endocrinology
Mahmut Ilker YilmazMetin Ozata

Abstract

To measure plasma adiponectin concentrations in patients with type 2 diabetes and to investigate any association with the severity of diabetic retinopathy, because adiponectin seems to be an important modulator for metabolic and vascular diseases. Seventy-four patients (mean age 46.8+/-5.1 years; body mass index (BMI), 26.8+/-2.10 kg/m(2)) and 54 healthy volunteers (mean age 46.8+/-5.4 years; BMI 26.47+/-2.33 kg/m(2)) were included. Adiponectin concentrations in the patients were significantly lower than those in controls (4.71+/-2.11 microg/ml for patients, n=74; 15.95+/-3.72 microg/ml for controls, n=54; P<0.001). In the patients group there was a significant negative correlation between adiponectin and homeostasis model assessment index (r=-0.318, P=0.006 respectively). Plasma adiponectin concentrations in patients with proliferative diabetic retinopathy (n=20; 3.16+/-1.83 microg/ml) or non-proliferative diabetic retinopathy (n=24; 3.97+/-1.47 microg/ml, P=0.014) were significantly lower than those in patients without diabetic retinopathy (n=30; 6.30+/-1.57 microg/ml, P=0.001). When the presence of diabetes was defined as the final variable in the conditional logistic regression model with the adiponectin concentration as th...Continue Reading

Citations

Nov 30, 2006·Reviews in Endocrine & Metabolic Disorders·Milagros Gloria Huerta
Mar 6, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Futoshi AnanHironobu Yoshimatsu
Mar 5, 2005·European Journal of Endocrinology·Mahmut Ilker YilmazMetin Ozata
Aug 12, 2014·BioMed Research International·Ersilia NigroAurora Daniele
Sep 6, 2007·The Tohoku Journal of Experimental Medicine·Zeynep EyiletenUmit Ozyurda
Jun 6, 2007·Medical Hypotheses·Allam Appa RaoUndurti N Das
Mar 16, 2007·Survey of Ophthalmology·Ning Cheung, Tien Y Wong
May 21, 2014·Journal of Diabetes Investigation·Chan-Hee JungChul-Hee Kim
Nov 26, 2015·Eye and Vision·Ryan LeeCharumathi Sabanayagam
Aug 22, 2015·Journal of Diabetes Research·Roxanne Crosby-NwaobiSobha Sivaprasad
Jul 3, 2015·Journal of Diabetes Research·F SemeraroC Costagliola
Jun 29, 2005·Diabetes Care·Christophe E M De BlockLuc F Van Gaal
May 8, 2016·Biochimica Et Biophysica Acta·Zhongjie FuLois E H Smith
Apr 16, 2019·Journal of Cellular Physiology·Rong LiXiaodi Wang
May 28, 2019·International Journal of Molecular Sciences·Sheetal ParidaDipali Sharma
Dec 17, 2010·Journal of Pediatric Endocrinology & Metabolism : JPEM·Serkan TapanOkan Ozcan
Jan 11, 2013·Physiological Reviews·Josephine M Forbes, Mark E Cooper
Dec 20, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yongqiang WangHua Jiang
Jul 8, 2015·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Chan-Hee JungJi-Oh Mok
Apr 4, 2020·Molecular Metabolism·Hui YuMalcolm J Low
Jun 9, 2016·Open Access Macedonian Journal of Medical Sciences·Soha M Abd El DayemMaha El-Tawil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.